Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic hepatitis C: a clinical overview

Z M Younossi1

  • 1Department of Gastroenterology, Cleveland Clinic, Cleveland Clinic Foundation, OH 44195, USA.

Cleveland Clinic Journal of Medicine
|May 1, 1997
PubMed
Summary

Understanding hepatitis C virus (HCV) progression is key to managing chronic liver disease. Research continues to explore effective treatments beyond interferon and understand factors influencing HCV

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan.

Journal of viral hepatitis·2018
Same author

Editorial: direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection-Author's reply.

Alimentary pharmacology & therapeutics·2018
Same author

Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality.

Alimentary pharmacology & therapeutics·2018
Same author

Quality of life in adolescents with hepatitis C treated with sofosbuvir and ribavirin.

Journal of viral hepatitis·2017
Same author

Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.

Alimentary pharmacology & therapeutics·2017
Same author

Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia.

Journal of viral hepatitis·2017

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) causes chronic liver disease, but its progression and influencing factors remain incompletely understood.
  • Current treatments like interferon have limited efficacy for chronic HCV infection.
  • HCV-induced cirrhosis and liver failure are leading reasons for liver transplantation in the US.

Purpose of the Study:

  • To summarize current knowledge on hepatitis C virus (HCV) analysis and disease progression.
  • To highlight the limitations of existing treatments and diagnostic methods for HCV.
  • To underscore the clinical significance of HCV-related liver disease.

Main Methods:

  • Review of recent advances in HCV analysis.
  • Categorization of HCV diagnostic tests into serologic and virologic methods.
  • Examination of treatment strategies for chronic HCV infection.

Main Results:

  • Improved understanding of HCV's role in chronic liver disease.
  • Identification of serologic and virologic tests for HCV detection.
  • Limited efficacy of interferon as a sole treatment for chronic HCV.

Conclusions:

  • Further research is needed to fully elucidate HCV natural history and progression factors.
  • Novel therapeutic strategies are essential to improve outcomes for chronic HCV patients.
  • HCV remains a significant public health concern, driving liver transplantation demand.

Related Experiment Videos